4//SEC Filing
BASTA JAMES 4
Accession 0001209191-22-015909
CIK 0001652130other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:34 PM ET
Size
12.7 KB
Accession
0001209191-22-015909
Insider Transaction Report
Form 4
BASTA JAMES
EVP, General Counsel
Transactions
- Award
Common Stock
2022-03-01+11,049→ 11,049 total - Award
Common Stock
2022-03-01+9,648→ 20,697 total - Award
Stock Option (right to buy)
2022-03-01+9,648→ 9,648 totalExercise: $79.85Exp: 2032-02-28→ Common Stock (9,648 underlying)
Footnotes (2)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]This option was granted on March 1, 2022 with respect to shares of Common Stock, with 33% vesting on January 1, 2023 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001792726
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:34 PM ET
- Size
- 12.7 KB